Litcius/Paper detail

ENO2-derived phosphoenolpyruvate functions as an endogenous inhibitor of HDAC1 and confers resistance to antiangiogenic therapy

Chenran Wang, Maohua Huang, Yuning Lin, Yiming Zhang, Jinghua Pan, Chang Jiang, Min-Jing Cheng, Shenrong Li, Wenzhuo He, Zhengqiu Li, Zhengchao Tu, Jun Fan, Hu-Hu Zeng, Jiahui Lin, Yongjin Wang, Nan Yao, Tongzheng Liu, Qi Qi, Xiangning Liu, Zhimin Zhang, Minfeng Chen, Liangping Xia, Dongmei Zhang, Wen‐Cai Ye

2023Nature Metabolism46 citationsDOI

Topics & Concepts

Cancer researchHDAC1Colorectal cancerHistone deacetylaseAcetylationBiologyCancerPharmacologyMedicineHistoneInternal medicineBiochemistryGeneHistone Deacetylase Inhibitors ResearchSignaling Pathways in DiseaseEpigenetics and DNA Methylation
ENO2-derived phosphoenolpyruvate functions as an endogenous inhibitor of HDAC1 and confers resistance to antiangiogenic therapy | Litcius